Literature DB >> 12134990

Late postoperative opacification of hydrophilic acrylic intraocular lenses.

Hakan E Oner, Ismet Durak, Osman A Saatci.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the incidence of postoperative opacification of hydrophilic acrylic intraocular lenses (IOLs) and discuss the surgical management. PATIENTS AND METHODS: Seventy-two eyes of 72 consecutive patients who received the same type of hydrophilic acrylic IOL (Intraocular Optical International, I.O.I., California, USA) after uneventful phacoemulsification were evaluated retrospectively. Systemic status, follow-up time, recognition time of IOL opacification, time lapse between implantation and explantation, and surgical technique during explantation were reported.
RESULTS: IOL opacification was noted in 3 patients (4.1%). Time lapse between implantation and first recognition of opacification was 6.3+/-1.5 months (range: 5-8 months). Two of the patients had insulin-dependent diabetes mellitus and both were on renal dialysis for diabetic nephropathy, whereas one had no systemic disease. Opacified hydrophilic acrylic IOLs were exchanged with Acrysof IOL, and no further opacification occurred after lens exchange.
CONCLUSION: Use caution on implantation of hydrophilic IOLs because late opacification is a serious complication requiring further surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134990

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  2 in total

1.  Perioperative complications and clinical outcomes of intraocular lens exchange in patients with opacified lenses.

Authors:  Roberto Fernández-Buenaga; Jorge L Alió; Laura Pinilla-Cortés; Rafael I Barraquer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-03       Impact factor: 3.117

2.  Analysis of aqueous humor calcium and phosphate from cataract eyes with and without diabetes mellitus.

Authors:  Chan Joong Kim; Sang Kyung Choi
Journal:  Korean J Ophthalmol       Date:  2007-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.